Prognostic factors for interstitial lung disease progression in rheumatoid arthritis: May methotrexate protect against progression?
Mustafa EkiciY BaytarAli AkdoğanGamze DurhanOrhan Macit ArıyürekUmut KalyoncuPublished in: Scandinavian journal of rheumatology (2024)
Our findings indicate a negative association between methotrexate use and ILD progression. These results should be confirmed in further studies.